Background
People with HIV (PWH) have a 1.5–2-fold increased risk of atherosclerotic cardiovascular disease. While most studies have focused on immune activation as the primary driver, the contribution of stromal cells, such as fibroblasts and smooth muscle cells, remains underexplored. Fibroblasts are key regulators of extracellular matrix (ECM) remodeling, thrombosis, and vascular inflammation. We hypothesized that aortic fibroblasts from PWH are chronically exposed to systemic inflammatory signals and acquire a transcriptional phenotype that promotes vascular dysfunction.
Methods
We analyzed aorta tissue from PWH on suppressive ART enrolled in the Last Gift rapid autopsy program at UCSD (n=18) and PWoH from the Adaptive Immune Cells and CMV in Atherosclerosis (ACACIA) Cohort at Vanderbilt (n=13).We performed single-cell RNA sequencing (10x Genomics Flex) on frozen aorta samples. Differential expressions were assessed using edgeR, and pathway enrichment was assessed using KEGG/Reactome.
Results
Participants were matched for age and sex. Among PWH, median age was 63 years and majority were male. 82.1% were virally suppressed at the time of death. The median last CD4 count was 195 cells/µL (IQR 100–347) and median nadir CD4 count was 80 cells/µL (IQR 44–165). The proportion of fibroblasts did not differ by HIV status (p = 0.98). However, fibroblasts from PWH (10650 cells) compared to PWoH (9581 cells) showed significant upregulation of prothrombotic tissue factor (F3 log₂FC = +3.6, FDR < 0.001), complement component (C3 FDR < 0.001), angiogenic mediators (NRP1, log₂FC = +2.4, FDR < 0.001, and FGF7, FDR < 0.001), and extracellular matrix (ECM) remodeling genes (PODN, THBS2, COL5A1; FDR < 0.01). Conversely, regulators of fibroblast quiescence and transcriptional control (CCN2, JUNB, ID1/2; FDR < 0.01) were downregulated. Pathway analysis revealed significant enrichment of coagulation cascades, ECM receptor interaction, complement activation, integrin signaling, and platelet activation pathways in PWH fibroblasts.
Conclusions
Aortic fibroblasts from PWH acquire a pathogenic transcriptional profile enriched for coagulation, complement, and ECM-remodeling pathways. These findings identify fibroblast activation as an underappreciated stromal mechanism that may exacerbate vascular inflammation and plaque instability in HIV-associated atherosclerotic cardiovascular disease. Targeting fibroblast-mediated pathways may represent a novel therapeutic strategy to reduce cardiovascular risk in PWH.
Table or Figure
